MYADM Antikörper (AA 51-150) (Cy5)

Produktnummer ABIN6944183

Dieses Anti-MYADM-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von MYADM in WB, IF (cc) und IF (p). Geeignet für Human.

Kurzübersicht für MYADM Antikörper (AA 51-150) (Cy5) (ABIN6944183)

Target: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MYADM Antikörper ist konjugiert mit Cy5

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Produktdetails anti-MYADM Antikörper (Cy5)

Bindungsspezifität: AA 51-150

Spezifität: This antibody's immunogen sequence has 91 % homology (10/11 residues) with the Rat MYADM protein and is predicted to work with Rat samples

Kreuzreaktivität: Human

Homologie: Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human MYADM

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu MYADM

Target: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Andere Bezeichnung: MYADM

Hintergrund:

Synonyms: MYADM, MYADM_HUMAN, myeloid associated differentiation marker, Myeloid upregulated protein, Myeloid-associated differentiation marker, Protein SB135.

Background: Myeloid-associated differentiation marker (MYADM) is a member of the MAL family with the unique features of having eight transmembrane regions and a ubiquitous pattern of expression and of being found localized at the plasma membrane. MYADM has been found to be associated with the differentiation of hematopoietic cells or acute promyelocytic leukemia cells. MYADM could serve as a new marker for hematopoietic differentiation and is a target for diagnostic, prognostic and/or therapeutic interventions.

Gen-ID: 91663

UniProt: Q96S97